COVID-19: DRAP approves local production of raw materials for anti-malarial drug Chloroquine
DRAP has also permitted over 50 companies to produce hand sanitizers.
The Drug Regulatory Authority (DRAP) of Pakistan has approved the local production of raw materials to help produce chloroquine.
The State Health Minister Dr. Zafar Mirza said that permission to conduct clinical trials of plasma therapy for COVID-19 patients has also been granted. Not only this, but trials of locally produced ventilators are also set to begin.
DRAP has permitted over 50 companies to produce hand sanitizers. These licensed companies would prepare sanitizers that are in accordance with the directives of the World Health Organization (WHO).
Previously, a research found out that the anti-malarial drug chloroquine could be used to cure the novel COVID-19. The drug has been making headlines ever since US President Donald Trump claimed that the Food and Drug Administration (FDA) has already approved it to treat the virus. This led to panic buying of the drug worldwide, simultaneously resulting in a shortage.
What are your views on this? Share in the comments bar below.
